Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

被引：0
|
作者：
Ling Qin
Samantha Stanley
Huihua Ding
Ting Zhang
Van Thi Thanh Truong
Teja Celhar
Anna-Marie Fairhurst
Claudia Pedroza
Michelle Petri
Ramesh Saxena
Chandra Mohan
机构：
[1] Tongji University School of Medicine,Department of Nephrology & Rheumatology, Shanghai Tenth People’s Hospital
[2] University of Houston,Department of Biomedical Engineering
[3] UT Houston,Department of Pediatrics
[4] Singapore Immunology Network,Department of Rheumatology
[5] Agency for Science,Department of Nephrology
[6] Technology,undefined
[7] and Research,undefined
[8] John Hopkins Medical University,undefined
[9] UT Southwestern Medical Center,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Lupus nephritis; Biomarkers; Plasmin; Tissue factor; Tissue factor pathway inhibitor; D-dimer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The anti-thrombotic effects of statins
    Kearney, D
    Fitzgerald, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) : 1305 - 1307
  • [32] Anti-thrombotic effects of higenamine
    Yun-Choi, HS
    Pyo, MK
    Park, KM
    Chang, KC
    Lee, DH
    PLANTA MEDICA, 2001, 67 (07) : 619 - 622
  • [33] ANTI-THROMBOTIC EFFECT OF SULPHINPYRAZONE
    NEWLAND, H
    LANCET, 1978, 1 (8074): : 1157 - 1157
  • [34] Appropriate Anti-Thrombotic/Anti-Thrombin Therapy for Thrombotic Lesions
    Iqbal, Zafar
    Rana, Gurinder
    Cohen, Marc
    CURRENT CARDIOLOGY REVIEWS, 2012, 8 (03) : 181 - 191
  • [35] Characterization of the pro-thrombotic state in CAPD patients
    Zupan, Irena Preloznik
    Sabovic, Miso
    Salobir, Barbara
    Ponikvar, Jadranka Buturovic
    RENAL FAILURE, 2008, 30 (06) : 597 - 602
  • [36] LIPID PROFILE AND PRO-THROMBOTIC DISORDER IN SYSTEMIC SCLEROSIS
    Ancuta, C.
    Pomirleanu, C.
    Ancuta, U.
    Iordache, C.
    Belibou, C.
    Chirieac, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S177 - S177
  • [37] Attenuated diurnal oscillations of pro-thrombotic markers in tetraplegia
    Iversen, PO
    De Groot, P
    Hjeltnes, N
    Andersen, TO
    Mowinckel, MC
    Sandset, PM
    REPORTS FROM THE 17TH INTERNATIONAL CONGRESS ON THROMBOSIS, 2002, : 59 - 62
  • [38] Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin
    Crescente, Marilena
    Armstrong, Paul C.
    Kirkby, Nicholas S.
    Edin, Matthew L.
    Chan, Melissa, V
    Lih, Fred B.
    Jiao, Jing
    Maffucci, Tania
    Allan, Harriet E.
    Mein, Charles A.
    Gaston-Massuet, Carles
    Cottrell, Graeme S.
    Mitchell, Jillian A.
    Zeldin, Darryl C.
    Herschman, Harvey R.
    Warner, Timothy D.
    FASEB JOURNAL, 2020, 34 (08): : 10027 - 10040
  • [39] Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules
    Muro, S
    Muzykantov, VR
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (18) : 2383 - 2401
  • [40] Endogenous pro-thrombotic biomarkers from the arm and leg may not have the same value
    Lattimer, Christopher R.
    Kalodiki, Evi
    Geroulakos, George
    Hoppensteadt, Debra
    Fareed, Jawed
    PHLEBOLOGY, 2016, 31 (04) : 275 - 282
12345